Powered by Scalable Akura™ Technology
Watch how we apply our scalable technology and organ-on-a-chip solutions to engineer powerful and flexible 3D in vitro platforms for drug efficacy and safety testing and the study of metabolic disease and cancers.
For Better, Safer Drugs. Faster.
Why Partner with InSphero?
Add the pioneer in 3D cell-based assay solutions and scaffold-free organ-on-a-chip technology to your drug R&D team and see immediate results.
Relevant
Work with 3D platforms precisely engineered to mimic human biology and save you years of model development and assay testing time.
Reliable
Rely on functionally robust, highly standardized microtissue models produced using ISO 9000 quality control processes.
Reproducible
Ensure reproducible data and minimize confounding factors regardless of the scale and complexity of your experiments.
“Addressing complex diseases requires the rare combination of pioneering innovation and biomedical expertise. As our discovery partner, InSphero gives us immediate access to new technologies, such as organ-on-a-chip systems, that provide deep mechanistic insights into complex diseases. They have become part of our research team, committed to helping us find a cure for type 1 diabetes.”
MATTHIAS VON HERRATH, MD
Professor and Director of the Center for Type 1 Diabetes Research
La Jolla Institute of Immunology
Vice President and Senior Medical Officer
Novo Nordisk